-
Ferring Announces FDA Acceptance of NDA Filing for Controlled Release Misoprostol Vaginal Insert for Decreasing Time to Vaginal Delivery in Women
in Uncategorized onFerring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA)…
0 -
New study showed desmopressin melt reduced sleep disruption in bedwetting children
in Uncategorized onPreliminary results from a new, prospective study presented today at the first Joint Congress of the International Children’s Continence…
-
Fonds de solidarité FTQ, CTI Life Sciences Fund and Ferring Pharmaceuticals Create a New Biotech in Québec
in Uncategorized onThe Fonds de solidarité FTQ (the “Fonds”), CTI Life Sciences Fund and Ferring Pharmaceuticals are pleased to announce…
-
FDA approves Ferring’s PREPOPIK™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) for colonoscopy prep
in Uncategorized onThe U.S. Food and Drug Administration (FDA) granted Ferring Pharmaceuticals Inc. approval to market PREPOPIK (sodium picosulfate, magnesium…
-
Ferring Pharmaceuticals Acquires Licensing Rights for Elobixibat from Albireo AB
in Uncategorized onFerring Pharmaceuticals (Ferring) and Albireo AB (Albireo) announced today that they have signed a license agreement under which Ferring has…
-
Ferring Pharmaceuticals donates $10 million to the Salk Institute for Biological Studies
in Uncategorized onFerring Pharmaceuticals, a global, specialty biopharmaceuticals company, has donated $10 million to support research at the Salk Institute…
-
New data show that FIRMAGON® (degarelix) is non-inferior to the combination of goserelin plus bicalutamide at reducing prostate volume in patients with advanced hormone-dependent prostate cancer while offering better relief from lower urinary tract symptoms
in Uncategorized onTwo new studies presented at the 27th Annual European Association of Urology (EAU) Congress reported that…
-
Ferring announces new million euro educational initiative with International Federation of Fertility Societies (IFFS) and Elsevier
in Uncategorized onWorld leader in fertility treatments, Ferring Pharmaceuticals, announced today at the 2012 Updates in Infertility Treatment (UIT) meeting that…
-
Acquisition of Cytokine
in TIMELINES onAcquisition of Cytokine PharmaSciences Inc. (CPSI) and its subsidiary, Controlled Therapeutics Scotland (CTS). The new entity called Ferring Controlled Therapeutics…
-
Similar remission results shown between once-daily 4g dose and twice-daily 2g doses of mesalazine (PENTASA®) in active ulcerative colitis
in Uncategorized onResults of a new study 1 presented today at the United European Gastroenterology Week (UEGW) congress in Stockholm demonstrate…
Archiwum Autora pulse
Articles by: pulse